- - # #Tareas - DONE CONTAR a [[Nerea]] con cosas importantes para [[STOP2030/Redes Sociales]] y otras cosas SCHEDULED: <2024-09-06 Fri> - - TODO QUE METAN en la [[Web]] de [[STOP2030]] que [[OMS]] ha designado a [[KEMRI]] como un centro colaborador en la vigilancia de NTDs [https://apps.who.int/whocc/Detail.aspx?XOAHM3sF/C/9r825fA94LA==](https://apps.who.int/whocc/Detail.aspx?XOAHM3sF/C/9r825fA94LA==) SCHEDULED: <2024-09-09 Mon> - Escrito un textito: - #+BEGIN_VERSE **ESACIPAC (KEMRI) designated as a WHO Collaborating Centre on monitoring and evaluation of NTDs** The Eastern and Southern Africa Centre of International Parasite Control (ESACIPAC), a part of KEMRI, has been designated as a WHO Collaborating Centre on monitoring and evaluation of neglected tropical diseases (NTDs) for the next four years. As part of their commitment, they will carry out activities to support disease mapping and impact assessment surveys for the control and elimination of NTDs. This newly designated WHO Collaborating Centre will be led by Doris Njomo, PhD, centre director of ESACIPAC, and Collins Okoyo, PhD, a statistician from KEMRI involved in the data collection, modelling and analysis within the STOP2030 consortium. The STOP2030 consortium congratulates ESACIPAC, and KEMRI, for this important achievement, and celebrates working together in developing our fixed-dose coformulation and making it available where it is most needed. #+END_VERSE - LO de KEMRI y OMS - La nueva guía de Strongy - En breve el DTAG publicará the TPP on diagnostics for St st. With that, these recommendations should have the right tools to complement treatment. - TODO RESPONDER a [[Nerea]] con el draft del email a partners de la [[newsletter]] SCHEDULED: <2024-09-09 Mon> - ### Original - #+BEGIN_VERSE Dear all The first issue of our collaborative newsletter was successfully launched during the summer, featuring contributions from all of you. Thank you for your valuable input. You can access the published content in this link. https://mailchi.mp/4a84cca6c552/the-bridge-1?e=73880ba532 While the launch was a success, we believe there is room for improvement in building our subscriber base. Subscription numbers were lower than anticipated; however, we view this initial issue as a valuable pilot case to showcase and actively promote for increased engagement. To support these efforts, we have developed a set of social media resources, which you can leverage within your networks to drive subscriptions. Attached, you will find a social media kit containing examples of ready-to-use posts and banners. Additionally, here is the link to the subscription page for ease of sharing. https://stop2030.us22.list-manage.com/subscribe?u=0ae85981ee38cc46519f27cfa&id=efc8832944 Looking ahead, next issue is scheduled for December. As we discussed, it will feature an article from one of our collaborating institutions. If anyone is interested in volunteering to write the next feature, please reach out. Thank you again for your ongoing support, and I look forward to hearing from you soon. Best regards, #+END_VERSE - ### Revisión - #+BEGIN_VERSE Dear all, The first issue of our collaborative newsletter was succesfully launched during the summer, featuring contributions from all of you. Thank you for your contributions and your willingness to participate. It was a good start, but we need to #+END_VERSE - TODO PENSAR sobre taller de [[GEPI]] sobre efectos secundarios del [[benznidazol]] que se hará en algún momento de [[2025]] SCHEDULED: <2025-01-08 Wed> - - - # #Eventos - DONE REUNIÓN [[STOP2030]] [[Scienseed]] SCHEDULED: <2024-09-06 Fri> - ### A tratar - {{embed ((66d58211-5274-456c-b2d3-3f6361df7028))}} - - ### Notas - - ### Decisiones - TODO PREGUNTAR a [[Ale Krolewiecki]] si tiene sentido hablar ocn [[Jose Muñoz]] para preguntar si hacemos una nota conjunta sobre el paper de farmacocinética con [[ISGlobal]] SCHEDULED: <2024-09-09 Mon> - Pressing issues: - Redes de agosto y septiembre - mandar a la peña de la newsletter un recordatorio de que se tienen que suscribir y motivar a otras personas que no sean ellos mismos a suscribirse. - responder a la gente de la newsletter - DONE MANDAR el manuscrito de farmacocinética y excel de eventos (compartido) SCHEDULED: <2024-09-06 Fri> - TODO REVISAR blogs de Scienseed SCHEDULED: <2024-09-09 Mon> - - -